Mainz Biomed is conducting a best-efforts public offering of up to 2.45M ordinary units and 2.49M pre-funded units. Each ordinary unit includes one ordinary share, one Class A warrant, and one Class B ...

The regulator found over 70% of SME IPO proceeds allegedly diverted to unrelated entities; ₹9 crore withdrawn in cash within ...